184 results
Page 2 of 10
8-K
EX-99.1
aap72m k5
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
8-K
pa4b0 h3a0c4mqp6fu2
4 Apr 23
Other Events
8:30am
8-K
EX-99.1
8q3f 009a53h
26 Oct 22
Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
8:00am
8-K
EX-99.1
ox0bqyb
15 Aug 22
Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
8:00am
8-K
EX-99.1
5ih4nz64axk7kwc2
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
8-K
EX-99.1
amzk8mnyt7vx 48nlll
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
8-K
EX-99.1
g4cgh9n amt8
22 Dec 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
p0obqvjtnj 8gua
15 Nov 21
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development
8:00am
8-K
EX-1.1
n4cvfee2en2cpjm 0hv0
5 May 21
Entry into a Material Definitive Agreement
5:02pm
424B5
726xl0zawu6xiq8b
5 May 21
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
o4om2 ovk
5 May 21
Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock
7:52am
8-K
20wrh5xmb1y6hkhuadj
19 Feb 21
Amendments to Articles of Incorporation or Bylaws
8:30am